POPULARITY
Categories
218 episodes with md phd
86 episodes with md phd
156 episodes with md phd
160 episodes with md phd
140 episodes with md phd
206 episodes with md phd
142 episodes with md phd
64 episodes with md phd
75 episodes with md phd
65 episodes with md phd
78 episodes with md phd
40 episodes with md phd
64 episodes with md phd
46 episodes with md phd
36 episodes with md phd
47 episodes with md phd
43 episodes with md phd
46 episodes with md phd
46 episodes with md phd
25 episodes with md phd
67 episodes with md phd
35 episodes with md phd
38 episodes with md phd
50 episodes with md phd
16 episodes with md phd
36 episodes with md phd
23 episodes with md phd
24 episodes with md phd
41 episodes with md phd
43 episodes with md phd
21 episodes with md phd
34 episodes with md phd
10 episodes with md phd
38 episodes with md phd
9 episodes with md phd
26 episodes with md phd
20 episodes with md phd
21 episodes with md phd
15 episodes with md phd
16 episodes with md phd
13 episodes with md phd
25 episodes with md phd
6 episodes with md phd
15 episodes with md phd
20 episodes with md phd
22 episodes with md phd
11 episodes with md phd
10 episodes with md phd
12 episodes with md phd
8 episodes with md phd
8 episodes with md phd
7 episodes with md phd
9 episodes with md phd
6 episodes with md phd
8 episodes with md phd
15 episodes with md phd
5 episodes with md phd
4 episodes with md phd
14 episodes with md phd
5 episodes with md phd
10 episodes with md phd
13 episodes with md phd
8 episodes with md phd
6 episodes with md phd
20 episodes with md phd
6 episodes with md phd
5 episodes with md phd
5 episodes with md phd
8 episodes with md phd
6 episodes with md phd
5 episodes with md phd
6 episodes with md phd
4 episodes with md phd
8 episodes with md phd
5 episodes with md phd
6 episodes with md phd
7 episodes with md phd
5 episodes with md phd
4 episodes with md phd
11 episodes with md phd
5 episodes with md phd
10 episodes with md phd
19 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
6 episodes with md phd
9 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
15 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
12 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
16 episodes with md phd
6 episodes with md phd
3 episodes with md phd
5 episodes with md phd
4 episodes with md phd
3 episodes with md phd
6 episodes with md phd
4 episodes with md phd
12 episodes with md phd
3 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
2 episodes with md phd
4 episodes with md phd
4 episodes with md phd
10 episodes with md phd
2 episodes with md phd
4 episodes with md phd
3 episodes with md phd
3 episodes with md phd
9 episodes with md phd
4 episodes with md phd
68 episodes with md phd
3 episodes with md phd
3 episodes with md phd
3 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
What happens when you ask ChatGPT to study every conversation you have had and tell you who you really are? One medical student did that, and what it told him changed how he sees his future in medicine. Jack Tiller is a medical student in an MD-PhD program, with doctoral work in neuroscience and neurodegeneration. This episode is based on his article "The reluctant achiever: Navigating identity in medical training," published on KevinMD. You will hear why the AI labeled him a reluctant achiever, and how a single line about having many possible lives but only one timeline stopped him cold. Jack explains how board-exam burnout, perfectionism, and an identity built on achievement all came into focus. He talks about exploring careers beyond clinical medicine, from science writing to policy, and about using AI alongside therapy to understand his own thinking. Press play to hear how AI helped one medical student see himself more clearly, and why he is giving himself permission to imagine a life beyond the path he was told to follow. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast
TWiP solves the case of the 39-year-old man originally from Guatemala, who moved to one of the NYC boroughs in 2023 and presented with headaches for nearly 1 year. Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Join the MicrobeTV Discord server Letters read on TWiP 284 TWiP study – information and survey New Case Recent ID consult: MD/PhD mother doing research, married with child 2 yo, female develops anal irritation, husband is fine, child is fine. Parasitic etiology is considered. Referred to academic ID providers, turns out she had this etiology considered, had received some treatment, got a little better, symptoms returned, treated again, got better, symptoms returned. Got some hard to find testing equipment, and confirm suspicion. Treat once, then again in two weeks. Not any better, still irritation. What do we do? HIV neg, no prior medical issues, no travel. Become a patron of TWiP Send your questions and comments to twip@microbe.tv Music by Ronald Jenkees
Send us Fan MailWhat are the most common eye injuries in children—and how can parents help prevent them?In this episode of Your Child Is Normal, Dr. Jessica Hochman sits down with Dr. Aaron Nagiel, pediatric retinal specialist and Chief of the Retina Division at Children's Hospital Los Angeles, to discuss children's eye health, vision safety, and the latest breakthroughs in retinal care.Dr. Nagiel explains how the retina works, common retinal conditions seen in children, and the warning signs parents should never ignore. He shares real-world stories about sports injuries, Nerf gun accidents, and laser pointer injuries that can lead to permanent vision loss, while offering practical advice on prevention and eye protection.They also discuss:• Common eye injuries in children and how to prevent them• When a red eye is concerning—and when it isn't• Warning signs of retinal disease• The role of screens, outdoor play, and dry eyes• Why children should wear prescribed glasses consistently• When eye symptoms warrant an urgent evaluation• Exciting advances in gene therapy and the future of pediatric retinal careThis episode is packed with practical takeaways that can help parents recognize problems early, protect their children's vision, and know when to seek specialized care.Dr. Aaron Nagiel is a pediatric retinal specialist at Children's Hospital Los Angeles and USC Roski Eye Institute, where he cares for children with retinal diseases, eye trauma, retinopathy of prematurity, and inherited retinal disorders. In collaboration with the Center for Personalized Medicine, he leads a state-of-the-art program specializing in the diagnosis and treatment of genetic eye disease, including gene therapy surgery.Dr. Aaron Nagiel earned his bachelor's degree from Harvard University summa cum laude, and then underwent combined MD and PhD training at Cornell University and The Rockefeller University in New York City. His PhD work was supported by an NIH fellowship and contributed to our understanding of how synapses form in the developing brain. After an internship at Memorial Sloan-Kettering Cancer Center, Dr. Nagiel completed both ophthalmology residency and vitreoretinal fellowship at the renowned Stein Eye Institute at UCLA.To contact Dr Nagiel:Please call 323-361-2347 or check out his websiteYour Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube: Ask Dr JessicaShop my favorite products for kids on Amazon hereIf you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information ...
In this episode of the Oncology Brothers podcast, we dived deep into the complexities of treating multiple myeloma, focusing on two challenging cases from the community. Joined by experts Marco Davila, MD PhD, from Roswell Park Comprehensive Cancer Center and Krina Patel, MD MSc, from MD Anderson Cancer Center, they discuss the nuances of treatment options for patients experiencing disease relapse post-transplant and disease progression while on maintenance therapy. Key topics included: The importance of thorough workup and repeat cytogenetics in high-risk multiple myeloma patients The debate between CAR T-cell therapy and bispecific antibodies as treatment options Strategies for managing patients with comorbidities and the role of shared decision-making in treatment planning Insights into the side effects associated with CAR-T and bispecific therapies, including infection risks and neurological symptoms Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Follow us on social media: X/Twitter: https://x.com/oncbrothers Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explored the latest advancements in multiple myeloma treatment and the exciting potential for achieving long-term remission and even cure in select patient populations. Don't forget to like, subscribe, and hit the notification bell for more insightful discussions on oncology! #MultipleMyeloma, #CARTtherapy, #BispecificAntibody, #RelapsedMyeloma, #OncologyBrothers
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NUP865. CME/NCPD/CPE/AAPA/IPCE credit will be available until July 12, 2027.All-in for Transthyretin Amyloidosis: Refining Team-Based Approaches to Diagnosis, Treatment, and Lifesaving Patient-Centered Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NUP865. CME/NCPD/CPE/AAPA/IPCE credit will be available until July 12, 2027.All-in for Transthyretin Amyloidosis: Refining Team-Based Approaches to Diagnosis, Treatment, and Lifesaving Patient-Centered Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Alnylam Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.
Could you have PCOS and not know it? You sure can, says reproductive endocrinologist and menopause specialist Dr. Carla DiGirolamo, who is hopeful that the recent renaming of the condition from “polycystic ovary syndrome” (PCOS) to “polyendocrine metabolic ovarian syndrome” (PMOS) will help raise awareness—and improve care. This episode breaks down what PMOS actually is, why the new name matters, and how this androgen‑driven metabolic condition shows up across the lifespan, from irregular cycles and fertility struggles to increased cardiometabolic risk, especially once you hit the menopause transition. We also cover treatment options including metformin, inositol, and compelling new research on GLP‑1 receptor agonists, plus what all of this means for active midlife women when it comes to fueling, Reds/LEA risk, resistance training, and long‑term glucose control.Carla DiGirolamo, MD, PhD, is a Double Board Certified Reproductive Endocrinologist and Obstetrician/Gynecologist specializing in women's performance and menopausal medicine. She is also a Crossfit Level 1 trainer, Certified Nutrition Coach, and member of CrossFit Medical Society. She is a MedFit Care provider and provides weekly workouts and medical updates at her Substack Athletic Aging. She is an Endocrine Consultant for Wild Health and Women's Health Director at Eternal Health. Dr. DiGirolamo is now seeing patients for virtual consultations for menopausal care and performance optimization. Visit her website drcarlad.com to learn more about her services and schedule an appointment.Join us at Feisty Fest September 18-20, 2026: https://feisty.co/events/feisty-fest/Join the Feisty Strong STRONG Club: https://feisty.co/training/strong-club/ and use code: HITPLAY15 to save 15%Sign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/Learn More about our 2026 Feisty Events, including Bike Camps and Cycling Trips: https://feisty.co/events/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 20% off your order with code FEISTYBRAIN at https://www.previnex.com/ Wahoo: Use the code FEISTY2026 to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/WVhdr
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Localized HR-Positive Breast Cancer | Faculty Presentation 1: Advances in the Use of Endocrine Therapy for Localized HR-Positive Breast Cancer — Harold J Burstein, MD, PhD CME information and select publications
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KUG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 16, 2027.Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HCN865. CME/MOC/AAPA credit will be available until July 1, 2027.Scaling New Heights in Lung and Breast Cancer Care: Harnessing the Power of Antibody–Drug Conjugates in Patients With Brain Metastases In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KUG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 16, 2027.Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HCN865. CME/MOC/AAPA credit will be available until July 1, 2027.Scaling New Heights in Lung and Breast Cancer Care: Harnessing the Power of Antibody–Drug Conjugates in Patients With Brain Metastases In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HCN865. CME/MOC/AAPA credit will be available until July 1, 2027.Scaling New Heights in Lung and Breast Cancer Care: Harnessing the Power of Antibody–Drug Conjugates in Patients With Brain Metastases In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KUG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 16, 2027.Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HCN865. CME/MOC/AAPA credit will be available until July 1, 2027.Scaling New Heights in Lung and Breast Cancer Care: Harnessing the Power of Antibody–Drug Conjugates in Patients With Brain Metastases In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KUG865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 16, 2027.Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.
Send us Fan MailWe usually think of health ministers as politicians. Dr. Evis Sala, MD, PhD is something entirely different. She's one of the world's leading cancer imaging researchers who helped pioneer AI in radiology - and now she's responsible for the healthcare of an entire nation. What happens when a scientist takes the helm of public health?Our guest today is one of the world's leading physician-scientists in medical imaging who has recently taken on one of the biggest leadership challenges in healthcare.Dr. Evis Sala, MD, PhD ( https://www.kryeministria.al/en/ministrat/evis-sala/ ) currently serves as the Minister of Health and Social Protection of Albania ( https://shendetesia.gov.al/en/hap/ ). Before entering government, Dr. Sala built an extraordinary international career spanning the University of Cambridge, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and Rome's Policlinico Gemelli, while becoming internationally recognized for her pioneering work in advanced cancer imaging, precision diagnostics, women's cancers, and the integration of artificial intelligence into radiology.Holding both an MD from the University of Tirana and a PhD in Epidemiology from the University of Cambridge, Dr. Sala has spent decades helping shape how we detect, diagnose, and ultimately treat cancer. Today, she is applying that scientific rigor and international experience to improving the health of an entire nation.#EvisSala #Healthcare #PublicHealth #Medicine #ArtificialIntelligence #AI #Radiology #CancerResearch #PrecisionMedicine #CancerImaging #MedicalInnovation #DigitalHealth #HealthPolicy #Oncology #MRI #FutureOfMedicine #HealthcareInnovation #MedicalTechnology #SciencePodcast #ProgressPotentialPossibilitiesSupport the show
Dr. Dave Rabin, MD, PhD, a board-certified psychiatrist, neuroscientist, and author of A Simple Guide to Being Alive, joins Max to explain why modern life feels so overwhelming, how anxiety can be understood as a signal from the body, and what simple tools can help restore a sense of safety, calm, and connection.This episode is proudly sponsored by:AG1 is my favorite multivitamin now in delicious new flavors! Enjoy a free 1 year supply of vitamin D and 5 free AG1 travel packs with your first purchase. All you have to do is visit drinkag1.com/GENIUS.Timeline Nutrition makes MitoPure—a purified form of urolithin A, which studies suggest may provide powerful mitochondrial support for energy and longevity. Go to http://timelinenutrition.com/max for up to 39% off of mitopure gummies
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Funda Meric-Bernstam, MD, the department chair and Endowed Nellie B. Connally Chair in Breast Cancer, in the Department of Investigational Cancer Therapeutics, medical director of the Khalifa Institute for Personalized Cancer Therapy, and a professor of breast surgical oncology at The University of Texas MD Anderson Cancer Center in Houston; as well as a regular member of Cancer Biology at the University of Texas Houston Graduate School of Biomedical Sciences.Drs Camidge and Meric-Bernstam discussed Dr Meric-Bernstam's evolution from a science-focused student into a leader in precision oncology and early-phase drug development. Dr Meric-Bernstam was raised in a hybrid fashion between the US and Turkey, attending a science-focused boarding school before beginning medical school in Turkey and ultimately restarting her medical education at the Yale School of Medicine in New Haven, Connecticut. Drawn to both the immediacy of surgery and the questions of basic science, she pursued a surgical residency with built-in research time, spending 2 years at the National Institute of Health studying translational regulation, an experience she credited with making her fearless in tackling the unfamiliar.In this discussion, Dr Meric-Bernstam offered a candid look at building a career without a clear roadmap. She emphasized that clinician-investigators must work hard, arguing that a meaningful clinical presence sharpens translational research by revealing patients' true unmet needs. Her work spanning cell signaling, mTOR biology, window-of-opportunity trials, and genomic testing led her to direct MD Anderson's personalized cancer therapy efforts and grow its phase 1 program.Beyond administration, Meric-Bernstam reflected on lessons from the lab, including a year of lost data that taught her to scrutinize primary results at every step, and her conviction in patient-derived models and co-clinical trials. Ultimately, Dr Meric-Bernstam described a transformational moment in oncology, where AI, comprehensive profiling, and newly druggable targets will reshape combination therapy. She concluded by reaffirming her mission to improve cancer outcomes, calling it the best job in the world.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TPJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 29, 2027.Therapeutic Progress and IMPACT in CRC: Expert Guidance on Applying Rapidly Emerging Evidence on Immunotherapy and Molecular, Precision-Based Approaches in CRC Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Colorectal Cancer Alliance. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb, Exelixis, Inc., Johnson & Johnson, and Taiho Oncology, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PFX865. CME/MOC/AAPA/IPCE credit will be available until June 27, 2027.New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Genentech, a member of the Roche Group.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TWT865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until June 7, 2027.Traveling Along the TROP2-Targeted Therapy Pathway in NSCLC: Exploring the Established Role and Expanding Options In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PFX865. CME/MOC/AAPA/IPCE credit will be available until June 27, 2027.New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Genentech, a member of the Roche Group.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TWT865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until June 7, 2027.Traveling Along the TROP2-Targeted Therapy Pathway in NSCLC: Exploring the Established Role and Expanding Options In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TWT865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until June 7, 2027.Traveling Along the TROP2-Targeted Therapy Pathway in NSCLC: Exploring the Established Role and Expanding Options In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PFX865. CME/MOC/AAPA/IPCE credit will be available until June 27, 2027.New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Genentech, a member of the Roche Group.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TWT865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until June 7, 2027.Traveling Along the TROP2-Targeted Therapy Pathway in NSCLC: Exploring the Established Role and Expanding Options In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PFX865. CME/MOC/AAPA/IPCE credit will be available until June 27, 2027.New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Genentech, a member of the Roche Group.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TJT865. CME/AAPA/IPCE credit will be available until June 16, 2027.Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TJT865. CME/AAPA/IPCE credit will be available until June 16, 2027.Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TJT865. CME/AAPA/IPCE credit will be available until June 16, 2027.Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TJT865. CME/AAPA/IPCE credit will be available until June 16, 2027.Building Strong Communities of Care in NF1: Collaborative Strategies and Management Choices With MEK Inhibitors for NF1-PNs Across Age Groups In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neurofibromatosis Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Alexion, AstraZeneca Rare Disease and SpringWorks Therapeutics, Inc.Disclosure information is available at the beginning of the video presentation.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Mary (Nora) L. Disis, MD, a professor in the Clinical Research Division at Fred Hutchinson Cancer Center; as well as a professor in the Division of Hematology and Oncology, an adjunct professor of pathology in obstetrics and gynecology, holder of the Helen B. Slonaker Endowed Professorship for Cancer Research, director of the Cancer Vaccine Institute, and associate dean for Translational Health Science at the School of Medicine at the University of Washington in Seattle.Drs Camidge and Disis discussed Dr Disis's evolution from a science-focused student to a global leader in cancer immunology. Raised in a family that prioritized education, Disis found her passion for chemistry as a young adult before pursuing an MD and a master's degree. Although deeply drawn to practicing medicine in rural communities, she ultimately chose to focus on the field of tumor immunology.In the discussion, Disis offered a candid look at the strategic discipline required to succeed as a clinician-scientist. She emphasized the importance of protecting research time and refusing to let clinical duties overshadow her lab work. Her pioneering research involved identifying HER2 as a tumor antigen and developing vaccines that demonstrated significant long-term survival through intermolecular epitope spreading.Beyond the lab, Disis highlighted how her editorial roles allow her to observe scientific trends and maintain a broad understanding of the clinical landscape. Ultimately, Disis emphasized that the path to cancer prevention and vaccine licensing requires finance, focus, fortitude, and fearlessness. Having witnessed immunotherapy become a standard of care, she remains dedicated to climbing the mountain of vaccine development. By sifting through scientific “buzz” and maintaining deep focus, Disis believes the next frontier of cancer research lies in immunizing individuals to prevent cancer from ever developing.
Michael G. Fehlings MD, PhD, FRCSYi Lu, MD PhDRajiv Saigal, MD PhD
Dr. Wilner would love your feedback! Click here to send a text! Thanks!Many thanks to Rebecca Gilbert, MD, PhD, for joining me on Episode #166 of The Art of Medicine with Dr. Andrew Wilner. Dr. Gilbert is a movement disorders specialist at Bellevue Hospital in New York City and Chief Mission Officer of the American Parkinson's Disease Association. She trained at Memorial Sloan Kettering and Columbia University, where she studied under renowned movement disorders specialist Dr. Stanley Fahn. During our 35-minute conversation, Dr. Gilbert described the symptoms of Parkinson's disease and emphasized the importance of dopaminergic medications and regular exercise to improve quality of life. We also explored the intriguing and still unexplained observation that music can enhance movement in people with Parkinson's disease. Dr. Gilbert highlighted the new American Parkinson's Disease Association public service announcement launched for Parkinson's Awareness Month, “Do What You Do.” This campaign showcases people with Parkinson's who continue to pursue their passions despite the challenges of the disease. Finally, Dr. Gilbert reviewed recent advances in Parkinson's disease treatment, including adaptive deep brain stimulation and subcutaneous infusion pumps. She also discussed ongoing efforts to develop biomarkers that can diagnose the disease at an earlier stage. For more information about Parkinson's disease, please visit: www.support.apdaParkinson.org #Parkinsons @APDA @RebeccaGilbert #movementdisorders @theartofmedicine #dopamine #DBSPlease click "Fanmail" and share your feedback!If you enjoy an episode, please share with friends and colleagues. "The Art of Medicine with Dr. Andrew Wilner" is now available on Alexa! Just say, "Play podcast The Art of Medicine with Dr. Andrew Wilner!" To never miss a program, subscribe at www.andrewwilner.com. Follow me on Instagram: @andrewwilnermdX: @drwilnerlinkedin.com/in/drwilner Please rate and review each episode. To contact Dr. Wilner or to join the mailing list: www.andrewwilner.comThis production has been made possible in part by support from “The Art of Medicine's” wonderful sponsor, Locumstory.com, a resource where providers can get real, unbiased answers about locum tenens. If you are interested in locum tenens, or considering a new full-time position, please go to Locumstory.com.Or paste this link into your browser:https://locumstory.com/?source=DSP_directbuy_drwilnerpodcast...
Can The Short Coats make a card game that captures the twists and turns of medical school? Well, we've given it a try, and now we finally play it — the Game of Med School, a prototype card-based playthrough of the full medical school path, from premed clubs to residency match. Cyrus Barati, who helped build the game, takes on the Gunner identity and immediately gets routed to clinical years while still underwater on points. M4 Fallon Jung (pregnant, unbothered) draws the Resilient Student card and somehow converts a failed Step exam into a net positive. M3s Sarah Upton and Zach Grissom round out the cast, with Zach's Non-Traditional Student racking up an improbable collection of degrees, nursing licenses, and EMT certifications before anyone gets to medical school proper. The cards lead to real conversations: What's a post-bacc worth on an application? How do you handle a professionalism flag? What actually happens when your PI moves states mid-MD-PhD? How do you tell a patient bad news — and does a med student ever actually have to? Does your identity change any of that? The real question: would you play this game if we gave it away? Listener feedback is always welcome at https://theshortcoat.com/tellus!
This episode marks the 100th episode of The Chemical Sensitivity Podcast!Thank you very much to the Marilyn Brachman Hoffman Foundation for its support that makes this work possible.Gratitude to listeners and viewers around the world for being part of this journey. If you enjoy the podcast, please subscribe wherever you listen to podcasts and on YouTube, and share it with others who may benefit from these conversations.http://listen.chemicalsensitivitypodcast.org/Here's to 100 episodes and more to come!In this episode:What can the history of lead exposure teach us about risk, regulation, and MCS?Aaron Goodman speaks with Bruce Lanphear, MD, PhD, about lead as a model for understanding chemical harm.Topics include:What lead teaches us about body burden and cumulative exposureRisk, regulation, and the precautionary principleWhy listening to affected people matters—and lessons for MCSListen and subscribe: http://listen.chemicalsensitivitypodcast.org/Watch & subscribe on YouTube: https://www.youtube.com/@podcastingMCSLink: Dr. Bruce Lanphearhttps://www.sfu.ca/fhs/about/people/profiles/bruce-lanphear.htmlSupport the showThank you very much to the Marilyn Brachman Hoffman Foundation generously supporting the podcast!If you find the podcast helpful, please consider becoming a monthly or one-time supporter:https://www.chemicalsensitivitypodcast.org/1970633/supporters/newhttps://buymeacoffee.com/mcspodcast Follow the podcast on YouTube! Captions available in any language. Please follow the podcast on social media:FacebookInstagramXBlueSkyTikTok
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, guest host Erin Schenk, MD, PhD, at the University of Colorado Anschutz in Aurora, an associate professor of medicine in the Division of Medical Oncology, sat down with D. Ross Camidge, MD, PhD, to highlight Dr Camidge's storied career and life. Driven by a relentless curiosity that often manifested in him "interrogating" those around him, Camidge chose a career in medicine because of the immediate effect he saw it could have on people's lives.His path included a formative gap year working at McDonald's and serving as a caregiver for a man with cerebral palsy. After studying at Oxford, he faced a significant professional and personal low when pursuing his PhD at Cambridge. Struggling with a difficult project, he persevered by pivoting his research and finding resilience through peers, eventually returning to practicing clinical medicine and finding his calling in oncology due to its unique overlap of molecular biology and opportunities for deep patient connection.Seeking further opportunities, Dr Camidge moved to the United States to lead the lung cancer program at the University of Colorado School of Medicine. He became a pivotal figure in the development of targeted therapies, specifically crizotinib for ALK-positive lung cancer. Beyond drug development, he championed the use of molecular profiling and established a global remote second opinion program.In 2022, Dr Camidge's perspective shifted profoundly following his own lung cancer diagnosis. This experience forced him to evolve from a "questioning machine" into someone more amenable to accepting love and support. He now integrates this dual perspective into his work, emphasizing that oncology must go beyond science to address the human experience of treating real people.
Tracing a trajectory from her medical education in China through a masters degree and PhD in Japan and a fellowship at the National Cancer Institute, Lifang Hou, MD, PhD, has cultivated an international career which now includes spearheading global cancer prevention initiatives that span from Africa to South America. In this episode, she discusses her career journey and how her work in genetics, epigenetics, and early cancer detection is helping bring affordable screening and prevention strategies to underserved communities around the world.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Small Cell Lung Cancer | Faculty Presentation 2: Management of Relapsed/Refractory SCLC; Promising Investigational Agents and Strategies — Christine L Hann, MD, PhD CME information and select publications
Riley Behan-Bush found the MD/PhD program through a Google search. Hannah Van Ert had already started a career in nursing before a research lab changed her path completely. Eight years (!) of combined medical and scientist training later, they're in their final stretch — and it often didn't feel like a long slog of schooling. They sit down with MSTP faculty Darren Hoffman, PhD, and Martha Carvour, MD/PhD (CCOM Class of 2012) to talk about how it works, what this path actually costs, who gets access to it, and whether federal funding cuts are about to make it a lot harder to find out.
© 2020-2026 Ivy Podcast Discovery LLC
